ZNF260 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.51269999859593E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.68069999999921E-05 |
Normal-vs-Stage2 |
1.220070E-02 |
Normal-vs-Stage3 |
2.86559997952907E-09 |
Normal-vs-Stage4 |
1.27650001680024E-09 |
Stage1-vs-Stage2 |
7.494400E-01 |
Stage1-vs-Stage3 |
8.385400E-04 |
Stage1-vs-Stage4 |
1.298540E-03 |
Stage2-vs-Stage3 |
1.042210E-01 |
Stage2-vs-Stage4 |
1.151780E-01 |
Stage3-vs-Stage4 |
9.345800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.57230000527886E-08 |
Normal-vs-AfricanAmerican |
3.1562999991408E-08 |
Normal-vs-Asian |
6.168000E-01 |
Caucasian-vs-AfricanAmerican |
1.029850E-01 |
Caucasian-vs-Asian |
2.388200E-01 |
AfricanAmerican-vs-Asian |
3.974000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.66450000449458E-08 |
Normal-vs-Female |
1.42719999995933E-06 |
Male-vs-Female |
4.309000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.162330E-04 |
Normal-vs-Age(41-60Yrs) |
3.95810000000107E-05 |
Normal-vs-Age(61-80Yrs) |
4.99480001803221E-09 |
Normal-vs-Age(81-100Yrs) |
3.52339999953877E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.139400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.398400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.366800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.355700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.980800E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.545010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.214200E-01 |
Normal-vs-Grade 2 |
4.135100E-03 |
Normal-vs-Grade 3 |
6.5536465143623E-12 |
Normal-vs-Grade 4 |
1.63702384980979E-12 |
Grade 1-vs-Grade 2 |
4.314400E-01 |
Grade 1-vs-Grade 3 |
7.720500E-03 |
Grade 1-vs-Grade 4 |
1.235130E-04 |
Grade 2-vs-Grade 3 |
1.180710E-04 |
Grade 2-vs-Grade 4 |
8.06349997883871E-09 |
Grade 3-vs-Grade 4 |
1.604260E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.798500E-03 |
Normal-vs-ccB subtype |
1.75840000338212E-08 |
ccA subtype-vs-ccB subtype |
5.220000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.25949999990804E-07 |
Normal-vs-N1 |
1.56932999999526E-05 |
N0-vs-N1 |
6.745700E-02 |
|
|